Table:
begin	end	state
1	19	non-cytoplasmic
20	40	transmembrane
41	46	cytoplasmic
47	71	transmembrane
72	75	non-cytoplasmic
76	107	cytoplasmic
108	135	transmembrane
136	146	non-cytoplasmic
147	179	transmembrane
180	197	cytoplasmic
198	217	transmembrane
218	256	non-cytoplasmic
257	279	transmembrane
280	317	cytoplasmic
318	342	transmembrane
343	353	non-cytoplasmic
354	377	transmembrane
378	387	cytoplasmic
388	406	transmembrane
407	417	non-cytoplasmic
418	446	transmembrane
447	466	cytoplasmic
467	487	transmembrane
488	500	non-cytoplasmic

Input:
>WP_097141773.1 NCBI__GCF_900220975.1:WP_097141773.1
MDLMSNLALGFSTAMSLQNLGLAFIGCLVGTLIGILPGVGPIATITMLLPITFGIDPVGA
LIMLAGIYYGAQYGGSTSAILVNIPGEAGSVVTALDGHAMAKKGRAGAALGISAIGSFIA
GCIATVVIAALAVPLTDLALRFGPTDYFALMVMGLVFAVVLAHGSVLKAVAMILLGILLS
TIGSDLETGQARMTFGSLHLADGIDFAVLAMGIFGFAEVLRNLEGGEQRDVIRGTMGPLL
PTREEMRRSIAPILRGTGLGSVLGMLPGNGAVLAPFASYTLEKKLAKRPQDFGKGAIEAV
AGPESANNAGAQTSFIPLLTLGIPPNAVMAIMVGAMMIQGIVPGPQVMTESPALFWGMIA
SMWIGNLMLLVINLPLVGMWVRLLKVPYRLLFPAILIFSCIGIYSIDNNPMDVVFTGGFA
IAGYLLIKMGFEPAPLLLGFVLGHLIEENLRRAMLLSRGELSTFAENPLSLILLMISVGL
LLLSALPTLRAKREEVFVED

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server